Good trial results for new asthma treatment

Israel’s Teva reported that Phase III trial results for its asthma treatment reslizumab reduced the frequency of attacks by 50 – 60% compared to placebo.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *